GlassScriptPhysician profile
Ezra Ben Riber
NPI 1487610697
$5,050.07
in general payments reported to CMS, 2019-2025
55 companies · $705 in 2025
The $705 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $900 · 2021: $953 · 2022: $878 · 2023: $692 · 2024: $269 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,665.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,016.88 | 2019-2025 | General - Therapies, General - Pain Management, Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $553.81 | 2019-2024 | Relistor |
| Electronic Waveform Lab, INC. | $354.41 | 2020 | |
| Spr Therapeutics, INC | $224.00 | 2022-2024 | Sprint Pns System |
| Arbor Pharmaceuticals, INC. | $175.98 | 2019-2022 | |
| Virtus Pharmaceuticals LLC | $170.47 | 2020-2021 | |
| Ibsa Pharma INC. | $154.62 | 2020-2023 | Tirosint, Licart |
| Pfizer INC. | $153.67 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $138.17 | 2019-2023 | Ztlido |
| Medtronic, INC. | $129.59 | 2022-2024 | Intellis Adaptivestim |
| Grt US Holding, INC. | $121.05 | 2021-2022 | |
| Amgen INC. | $116.72 | 2019-2022 | |
| Sentynl Therapeutics, INC. | $99.42 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $96.46 | 2019-2021 | |
| Abbvie INC. | $92.47 | 2021-2025 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ezra Riber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.